Ahern G P, Junankar P R, Dulhunty A F
Membrane Biology Program, John Curtin School of Medical Research, Australian National University, Canberra, Australia.
Neurosci Lett. 1997 Apr 4;225(2):81-4. doi: 10.1016/s0304-3940(97)00193-6.
In this report we demonstrate that the immunosuppressive drug, rapamycin, can reversibly activate the skeletal muscle ryanodine receptor calcium release channel (RyR) in terminal cisternae vesicles incorporated into planar lipid bilayers. This reveals a second mechanism of activation of RyRs by rapamycin. Irreversible channel activation and openings to subconductance levels are seen when rapamycin forms a complex with and removes the tightly bound 12 kDa FK506-binding protein (FKBP12) from the RyR. We show here that micromolar rapamycin activates RyRs which were previously 'stripped' of > 95% of their FKBP12s. Rapamycin caused a 6-fold increase in mean current, which was largely reversible, but no increase in the fraction of openings to subconductance levels. Therefore native RyRs, stripped of FKBP12, are directly activated by the macrocyclic lactone, rapamycin.
在本报告中,我们证明免疫抑制药物雷帕霉素可在整合到平面脂质双分子层中的终末池小泡中可逆地激活骨骼肌兰尼碱受体钙释放通道(RyR)。这揭示了雷帕霉素激活RyRs的第二种机制。当雷帕霉素与RyR形成复合物并从其上移除紧密结合的12 kDa FK506结合蛋白(FKBP12)时,会出现不可逆的通道激活并开放至亚电导水平。我们在此表明,微摩尔浓度的雷帕霉素可激活先前已去除>95% FKBP12的RyRs。雷帕霉素使平均电流增加了6倍,这在很大程度上是可逆的,但开放至亚电导水平的比例没有增加。因此,去除了FKBP12的天然RyRs可被大环内酯类药物雷帕霉素直接激活。